Navigation Links
Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
Date:9/12/2007

EXTON, Pa., Sept. 12 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its first quarter ended September 30, 2007 at 7:00 A.M. Eastern Time on Friday, October 19, 2007.

Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Friday, October 19, 2007 at 9:00 A.M. Eastern Time.

To participate in the teleconference call, dial 1-651-291-5254. The teleconference call will also be available for replay starting Friday, October 19, 2007 at 12:30 P.M. Eastern Time through Friday, October 26, 2007 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 886702.

Individuals interested in listening to the teleconference may also do so over the Internet at http://www.kenseynash.com. To listen to the live teleconference call, please go to the http://www.kenseynash.com website and choose the Investor Relations page. Please allow 15 minutes prior to the start of the call to register and download and/or install any necessary software. A replay of the teleconference will be archived on the http://www.kenseynash.com website and may be accessed following the teleconference.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the produ
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
2. PM announces a new health care order for India
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. PowderMed Announces Needle-Less Flu Vaccine
10. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
Life After Death: Organ Donation
...the first study to show that even mildly abnormal ...n elderly men undergoing major surgery," said Dr. ...dical Center and Brown University in Rhode Island....rovidence Veterans Affairs Medical Center and The ...
...s at the University of California, Riverside have ...nces, for two key proteins in the 'dragline silk' ...ad to a variety of new materials for industrial, m...dow spiders dragline silk is a standout compared t...
...-Hajam carefully placed the glass jars over the sl...n to pump out the air. In the ensuing vacuum , the... into the clear containers. "The Assyrians, the C... used to practice cupping to draw out the corrupt ...
Other Medicine News:Health News:Life After Death: Organ Donation 2Health News:Life After Death: Organ Donation 3Health News:Abnormality in the Red Blood Count Cell Poses High Risks 2Health News:Genetic Secrets Behind the Dragline Silk 2Health News:Ancient Healing Technique Gains New Popularity in Iraq 2
(Date:10/6/2008)...erapy is More Likely to Induce Steroid-Free Remi... Immunomodulator, Azathioprine, ...ted for the first time,from the Phase 3b Study of ...ators and Biologic Therapy (SONIC) may provide new...th moderate to severe Crohn,s disease.,According t...
(Date:10/6/2008)... 6 /- Complete,Genomics Inc., a newly...g,company, and the Institute for Systems Biology (...populationwide human genome studies., In phase on...roprietary,DNA sequencing technology to sequence f...ce proof-of-concept has been demonstrated, ISB and...
(Date:10/6/2008)...r 9:00 AM ET Today -, SEATTLE, Oct. 6 /PRNewswire... announced today that it has completed the planned...le-blind, placebo-controlled IMPACT,(IMmunotherapy... as D9902B),clinical trial designed to assess the ...cellular immunotherapy PROVENGE(R) (sipuleucel-T) ...
(Date:10/6/2008)...eks of Radiation Therapy -, Event: Watch Single-Do..., October 22, 2008, 3 - 4 p.m. by visiting htt... Oct. 6 / Questions raced through Vel...ancer in May. Would she have the,tumor removed or ...rapy?, , To view the Multimedia News Release, go...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Caring com Joins Entrepreneurs Foundation as 200th Member 14153 1Caring com Joins Entrepreneurs Foundation as 200th Member 14153 2Researcher provides tool to enable determination of age of anchovies with greater precision 2476 1Researcher provides tool to enable determination of age of anchovies with greater precision 2476 2Researcher provides tool to enable determination of age of anchovies with greater precision 2476 3MHA to Release Findings of Independent Long Term Care Member Study 14150 1MHA to Release Findings of Independent Long Term Care Member Study 14150 2CardioDynamics Board of Directors Proposes Reverse Split 1 3A7 of Companys Shares 14148 1CardioDynamics Board of Directors Proposes Reverse Split 1 3A7 of Companys Shares 14148 2
...BRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2007 - Glo... biopharmaceutical,company, announced today that t...nted Fast Track designation for its novel histone,...rapy of,previously treated peripheral T-cell lymph...hat it has reached an agreement with the,FDA under...
...ompany Misrepresented Prescription Pain,Reliever t... May 10, 2007-The U.S. Food and Drug,Administratio...announced today that The Purdue Frederick Company,...resolve criminal charges and civil,liabilities in ...,market and sell OxyContin, a powerful prescripti...
Other Medicine Technology:Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma 2Gloucester Pharmaceuticals Receives Fast Track Designation for,Romidepsin in Peripheral T-Cell Lymphoma 3FDA Announces Results of Investigation Into Illegal Promotion of,OxyContin by The Purdue Frederick Company, Inc. 2
Standard locking pliers.
The double action wire cutter has both side and end cutting capabilities.
...he companys core product. It is created using the ... for the screening of eye and non-eye diseases and...xamination basis and is non-reimbursable. The opto...field of view of the patients retina which is view...
...angular Camera ,IS2s Single Rectangular Head...nd SPECT studies. Offering flexibility, ease of us...r Head Camera is an ideal camera for bone and orga...d also acquires excellent cardiac images. Its also...
Medicine Products: